SCHEMBL24415315

SCHEMBL24415315

CC1(C)CC(=O)C=C(N2CCC(O)CC2)C1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.72
MAPT P10636 1/20 0.68
HPGD P15428 1/20 0.68
NPSR1 Q6W5P4 1/20 0.39
NPC1 O15118 6/20 0.38
SMN1; SMN2 Q16637 5/20 0.38
RAB9A P51151 5/20 0.38
LMNA P02545 4/20 0.38
APOBEC3A P31941 3/20 0.38
APOBEC3G Q9HC16 3/20 0.38
CTDSP1 Q9GZU7 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HTT P42858 4/20 0.37
NR2F2 P24468 2/20 0.37
NOD2 Q9HC29 1/20 0.37
GALR3 O60755 1/20 0.37
TP53 P04637 1/20 0.37
MITF O75030 1/20 0.37
NPY1R P25929 1/20 0.37
F10 P00742 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12869178 0.84 ALDH1A1 (1.00) ALDH1A1MAPTHPGDNPSR1NPC1
SCHEMBL24415299 0.81 MAPT (0.93) ALDH1A1MAPTHPGDNPSR1NPC1
SCHEMBL23229431 0.81 MAPT (1.00) ALDH1A1MAPTHPGDNPSR1NPC1
SCHEMBL5970126 0.80 MAPT (0.96) ALDH1A1MAPTHPGDNPSR1NPC1
SCHEMBL15431904 0.78 ALDH1A1 (0.86) ALDH1A1MAPTHPGDNPSR1NPC1
SCHEMBL10724563 0.77 ALDH1A1 (1.00) ALDH1A1MAPTHPGDNPC1SMN1; SMN2
SCHEMBL12618676 0.77 ALDH1A1 (0.77) ALDH1A1MAPTHPGDNPC1SMN1; SMN2
SCHEMBL12618675 0.75 ALDH1A1 (0.67) ALDH1A1MAPTHPGDNPSR1NPC1
SCHEMBL19308592 0.74 ALDH1A1 (0.77) ALDH1A1MAPTHPGDNPSR1NPC1
SCHEMBL15448164 0.74 ALDH1A1 (0.77) ALDH1A1MAPTHPGDNPSR1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220144769-A1 COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2022-05-12 US disclosed
US-20220144759-A1 COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2022-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220144769-A1 COMPOUND CBR3, SFXN3, CBR1 ALDH1A1 928/4885MAPT 4568/4885HPGD 2255/4885
US-20220144759-A1 COMPOUND SFXN3, SFXN1, CBR3 ALDH1A1 1450/4885MAPT 4522/4885HPGD 1584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.